Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antreas Afantitis is active.

Publication


Featured researches published by Antreas Afantitis.


European Journal of Medicinal Chemistry | 2009

Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts

Georgia Melagraki; Antreas Afantitis; Olga Igglessi-Markopoulou; Anastasia Detsi; Maria Koufaki; Christos Kontogiorgis; Dimitra Hadjipavlou-Litina

In the present work a series of novel coumarin-3-carboxamides and their hybrids with the alpha-lipoic acid were designed, synthesized and tested as potent antioxidant and anti-inflammatory agents. The new compounds were evaluated for their antioxidant activity, their activity to inhibit in vitro lipoxygenase and their in vivo anti-inflammatory activity. In general, the derivatives were generally found to present antioxidant and anti-inflammatory activities. Discussion is made based on the results for the structure-activity relationships in order to define the structural features required for activity.


Journal of Cheminformatics | 2010

Collaborative development of predictive toxicology applications

Barry Hardy; Nicki Douglas; Christoph Helma; Micha Rautenberg; Nina Jeliazkova; Vedrin Jeliazkov; Ivelina Nikolova; Romualdo Benigni; Olga Tcheremenskaia; Stefan Kramer; Tobias Girschick; Fabian Buchwald; Jörg Wicker; Andreas Karwath; Martin Gütlein; Andreas Maunz; Haralambos Sarimveis; Georgia Melagraki; Antreas Afantitis; Pantelis Sopasakis; David Gallagher; Vladimir Poroikov; Dmitry Filimonov; Alexey V. Zakharov; Alexey Lagunin; Tatyana A. Gloriozova; Sergey V. Novikov; Natalia Skvortsova; Dmitry Druzhilovsky; Sunil Chawla

OpenTox provides an interoperable, standards-based Framework for the support of predictive toxicology data management, algorithms, modelling, validation and reporting. It is relevant to satisfying the chemical safety assessment requirements of the REACH legislation as it supports access to experimental data, (Quantitative) Structure-Activity Relationship models, and toxicological information through an integrating platform that adheres to regulatory requirements and OECD validation principles. Initial research defined the essential components of the Framework including the approach to data access, schema and management, use of controlled vocabularies and ontologies, architecture, web service and communications protocols, and selection and integration of algorithms for predictive modelling. OpenTox provides end-user oriented tools to non-computational specialists, risk assessors, and toxicological experts in addition to Application Programming Interfaces (APIs) for developers of new applications. OpenTox actively supports public standards for data representation, interfaces, vocabularies and ontologies, Open Source approaches to core platform components, and community-based collaboration approaches, so as to progress system interoperability goals.The OpenTox Framework includes APIs and services for compounds, datasets, features, algorithms, models, ontologies, tasks, validation, and reporting which may be combined into multiple applications satisfying a variety of different user needs. OpenTox applications are based on a set of distributed, interoperable OpenTox API-compliant REST web services. The OpenTox approach to ontology allows for efficient mapping of complementary data coming from different datasets into a unifying structure having a shared terminology and representation.Two initial OpenTox applications are presented as an illustration of the potential impact of OpenTox for high-quality and consistent structure-activity relationship modelling of REACH-relevant endpoints: ToxPredict which predicts and reports on toxicities for endpoints for an input chemical structure, and ToxCreate which builds and validates a predictive toxicity model based on an input toxicology dataset. Because of the extensible nature of the standardised Framework design, barriers of interoperability between applications and content are removed, as the user may combine data, models and validation from multiple sources in a dependable and time-effective way.


European Journal of Medicinal Chemistry | 2011

Ligand - based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks

Antreas Afantitis; Georgia Melagraki; Panayiotis A. Koutentis; Haralambos Sarimveis; George Kollias

In this work we have developed an in silico model to predict the inhibition of β-amyloid aggregation by small organic molecules. In particular we have explored the inhibitory activity of a series of 62 N-phenylanthranilic acids using Kohonen maps and Counterpropagation Artificial Neural Networks. The effects of various structural modifications on biological activity are investigated and novel structures are designed using the developed in silico model. More specifically a search for optimized pharmacophore patterns by insertions, substitutions, and ring fusions of pharmacophoric substituents of the main building block scaffolds is described. The detection of the domain of applicability defines compounds whose estimations can be accepted with confidence.


Molecular Diversity | 2006

A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis

Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A. Koutentis; John Markopoulos; Olga Igglessi-Markopoulou

SummaryA quantitative–structure activity relationship was obtained by applying Multiple Linear Regression Analysis to a series of 80 1-[2-hydroxyethoxy-methyl]-6-(phenylthio) thymine (HEPT) derivatives with significant anti-HIV activity. For the selection of the best among 37 different descriptors, the Elimination Selection Stepwise Regression Method (ES-SWR) was utilized. The resulting QSAR model (R2CV = 0.8160; SPRESS = 0.5680) proved to be very accurate both in training and predictive stages.


Toxicology and Applied Pharmacology | 2013

Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.

Liying Zhang; Alexander Sedykh; Ashutosh Tripathi; Hao Zhu; Antreas Afantitis; Varnavas D. Mouchlis; Georgia Melagraki; Ivan Rusyn; Alexander Tropsha

Identification of endocrine disrupting chemicals is one of the important goals of environmental chemical hazard screening. We report on the development of validated in silico predictors of chemicals likely to cause estrogen receptor (ER)-mediated endocrine disruption to facilitate their prioritization for future screening. A database of relative binding affinity of a large number of ERα and/or ERβ ligands was assembled (546 for ERα and 137 for ERβ). Both single-task learning (STL) and multi-task learning (MTL) continuous quantitative structure-activity relationship (QSAR) models were developed for predicting ligand binding affinity to ERα or ERβ. High predictive accuracy was achieved for ERα binding affinity (MTL R(2)=0.71, STL R(2)=0.73). For ERβ binding affinity, MTL models were significantly more predictive (R(2)=0.53, p<0.05) than STL models. In addition, docking studies were performed on a set of ER agonists/antagonists (67 agonists and 39 antagonists for ERα, 48 agonists and 32 antagonists for ERβ, supplemented by putative decoys/non-binders) using the following ER structures (in complexes with respective ligands) retrieved from the Protein Data Bank: ERα agonist (PDB ID: 1L2I), ERα antagonist (PDB ID: 3DT3), ERβ agonist (PDB ID: 2NV7), and ERβ antagonist (PDB ID: 1L2J). We found that all four ER conformations discriminated their corresponding ligands from presumed non-binders. Finally, both QSAR models and ER structures were employed in parallel to virtually screen several large libraries of environmental chemicals to derive a ligand- and structure-based prioritized list of putative estrogenic compounds to be used for in vitro and in vivo experimental validation.


Molecular Diversity | 2010

A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs

Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A. Koutentis; Olga Igglessi-Markopoulou; George Kollias

A novel QSAR workflow is constructed that combines MLR with LS-SVM classification techniques for the identification of quinazolinone analogs as “active” or “non-active” CXCR3 antagonists. The accuracy of the LS-SVM classification technique for the training set and test was 100% and 90%, respectively. For the “active” analogs a validated MLR QSAR model estimates accurately their I-IP10 IC50 inhibition values. The accuracy of the QSAR model (R2 = 0.80) is illustrated using various evaluation techniques, such as leave-one-out procedure


European Journal of Medicinal Chemistry | 2009

A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas.

Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Olga Igglessi-Markopoulou; George Kollias


RSC Advances | 2014

Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles

Georgia Melagraki; Antreas Afantitis

{(R^{2}_{\rm LOO} =0.67)}


Journal of Computer-aided Molecular Design | 2006

Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniques

Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A. Koutentis; John Markopoulos; Olga Igglessi-Markopoulou


Molecular Diversity | 2009

Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors

Georgia Melagraki; Antreas Afantitis; Haralambos Sarimveis; Panayiotis A. Koutentis; George Kollias; Olga Igglessi-Markopoulou

and validation through an external test set

Collaboration


Dive into the Antreas Afantitis's collaboration.

Top Co-Authors

Avatar

Georgia Melagraki

National Technical University of Athens

View shared research outputs
Top Co-Authors

Avatar

Haralambos Sarimveis

National Technical University of Athens

View shared research outputs
Top Co-Authors

Avatar

Olga Igglessi-Markopoulou

National Technical University of Athens

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

George Kollias

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

John Markopoulos

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Eleni Vrontaki

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Giorgos Athanasellis

National Technical University of Athens

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge